Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists

被引：10

作者：

Ward, Simon E. ^{[1
]}

Eddershaw, Peter J. ^{[1
]}

Scott, Claire M. ^{[1
]}

Gordon, Laurie J. ^{[1
]}

Lovell, Peter J. ^{[1
]}

Moore, Susan H. ^{[1
]}

Smith, Paul W. ^{[1
]}

Starr, Kathryn R. ^{[1
]}

Thewlis, Kevin M. ^{[1
]}

Watson, Jeannette M. ^{[1
]}

机构：

[1] GlaxoSmithKline, Psychiat Ctr Excellence Drug Discovery & Mol Disc, Harlow CM19 5AW, Essex, England

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2008年 / 51卷 / 10期

关键词：

D O I：

10.1021/jm8001444

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

5-HT1 receptor antagonists have been discovered with good selectivity over the 5-HT transporter. This is the first report of highly potent, selective ligands for the 5-HT1A/B/D receptors with low intrinsic activity, which represent a useful set of molecules for further understanding the roles of the 5-HT1 receptor subtypes and providing new approaches,for the treatment of depression.

引用

页码：2887 / 2890

页数：4

共 50 条

[41] Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and Antagonist
Scott, James S.
Moss, Thomas A.
Balazs, Amber
Barlaam, Bernard
Breed, Jason
Carbajo, Rodrigo J.
Chiarparin, Elisabetta
Davey, Paul R. J.
Delpuech, Oona
Fawell, Stephen
Fisher, David, I
Gagrica, Sladjana
Gangl, Eric T.
Grebe, Tyler
Greenwood, Ryan D.
Hande, Sudhir
Hatoum-Mokdad, Holia
Herlihy, Kara
Hughes, Samantha
Hunt, Thomas A.
Hoan Huynh
Janbon, Sophie L. M.
Johnson, Tony
Kavanagh, Stefan
Klinowska, Teresa
Lawson, Mandy
Lister, Andrew S.
Marden, Stacey
McGinnity, Dermot F.
Morrow, Christopher J.
Nissink, J. Willem M.
O'Donovan, Daniel H.
Peng, Bo
Polanski, Radoslaw
Stead, Darren S.
Stokes, Stephen
Thakur, Kumar
Throner, Scott R.
Tucker, Michael J.
Varnes, Jeffrey
Wang, Haixia
Wilson, David M.
Wu, Dedong
Wu, Ye
Yang, Bin
Yang, Wenzhan
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (23) : 14530 - 14559
[42] SDZ 216-525, A SELECTIVE AND POTENT 5-HT1A RECEPTOR ANTAGONIST
SCHOEFFTER, P
FOZARD, JR
STOLL, A
SIEGL, H
SEILER, MP
HOYER, D
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 244 (03): : 251 - 257
[43] Discovery of potent, selective, orally bioavailable Stearoyl-CoA desaturase 1 inhibitors
Liu, Gang
Lynch, John K.
Freeman, Jennifer
Liu, Bo
Xin, Zhili
Zhao, Hongyu
Serby, Michael D.
Kym, Philip R.
Suhar, Tom S.
Smith, Harriet T.
Cao, Ning
Yang, Ruojing
Janis, Rich S.
Krauser, Joel A.
Cepa, Steven P.
Beno, David W. A.
Sham, Hing L.
Collins, Christine A.
Surowy, Teresa K.
Camp, Heidi S.
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (13) : 3086 - 3100
[44] Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders
Armani, Elisabetta
Rizzi, Andrea
Iotti, Nicolo
Saccani, Francesca
Di Lascia, Maria Rosaria
Tigli, Laura
Pappani, Alice
Marchini, Gessica
Murgo, Annalisa
Capelli, Anna Maria
Delcanale, Maurizio
Puccini, Paola
Villetti, Gino
Civelli, Maurizio
Beato, Claudia
Giuliani, Marta
Mundi, Claudia
Murarolli, Francesca
Pagano, Mafalda
Raveglia, Luca F.
Remelli, Rosaria
Amari, Gabriele
JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (08) : 5622 - 5656
[45] A SERIES OF POTENT AND SELECTIVE 5-HT1A RECEPTOR ANTAGONISTS RELATED TO WAY-100135 - SYNTHESES, SAR, AND MODELING STUDIES
BILL, SJ
CLIFFE, IA
DOVER, GM
FLETCHER, A
FORSTER, EA
IFILL, AD
MANSELL, HL
PITT, W
REILLY, Y
WHITE, AC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 59 - MEDI
[46] Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors
Patel, Dipam
Jain, Mukul
Shah, Shailesh R.
Bahekar, Rajesh
Jadav, Pradip
Joharapurkar, Amit
Dhanesha, Nirav
Shaikh, Mubeen
Sairam, Kalapatapu V. V. M.
Kapadnis, Prashant
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1111 - 1117
[47] Involvement of presynaptic 5-HT1A and benzodiazepine receptors in the anticonflict activity of 5-HT1A receptor antagonists
Wesolowska, A
Paluchowska, M
Chojnacka-Wójcik, E
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 471 (01) : 27 - 34
[48] EFFECTS OF NOVEL 5-HT1A RECEPTOR ANTAGONISTS ON MEASURES OF POSTSYNAPTIC 5-HT1A RECEPTOR ACTIVATION IN-VIVO
THIELEN, RJ
FRAZER, A
LIFE SCIENCES, 1995, 56 (07) : PL163 - PL168
[49] Arylpiperazide derivatives of phenylpiperazines as a new class of potent and selective 5-HT1B receptor antagonists
Jorand-Lebrun, C
Pauwels, PJ
Palmier, C
Chopin, P
Moret, C
Marien, M
Halazy, S
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (24) : 3183 - 3188
[50] Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT
Parthasarathy, Saravanan
Henry, Kenneth
Pei, Huaxing
Clayton, Josh
Rempala, Mark
Johns, Deidre
De Frutos, Oscar
Garcia, Pablo
Mateos, Carlos
Pleite, Sehila
Wang, Yong
Stout, Stephanie
Condon, Bradley
Ashok, Sheela
Lu, Zhohai
Ehlhardt, William
Raub, Tom
Lai, Mei
Geeganage, Sandaruwan
Burkholder, Timothy P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (10) : 1887 - 1891

← 1 2 3 4 5 →